About Apotex
Data last updated:
Apotex is a company based in Toronto (Canada) founded in 1974 was acquired by SK Capital in September 2022. The company has 1,236 employees as of April 09, 2024. Apotex has completed 2 acquisitions, including Aveva and Searchlight Pharma.
- Headquarter Toronto, Canada
- Employees 1236 as on 09 Apr, 2024
- SectorsHealthcare
- PhoneLocked
- WebsiteLocked
- SocialLocked
- Legal Name Apotex Health Corp.
- Annual Revenue$76.64 M (USD)16.82as on Mar 31, 2023
- Net Profit$11.03 M (USD)109.79as on Mar 31, 2023
- EBITDA$17.41 M (USD)24.96as on Mar 31, 2023
- Latest Funding RoundNot available
- Investors
- Employee Count1236
as on Apr 09, 2024
- Investments & AcquisitionsAveva
& 1 more
- Acquired bySK Capital
(Sep 22, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Apotex
Apotex is a publicly listed company on the TSX with ticker symbol APTX in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Apotex
Unlock access to complete
Funding Insights of Apotex
Detailed funding history for Apotex
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Apotex
Apotex has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SK Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A global private investment firm focused on specialty sectors. | Locked | Locked | Locked |
Investor details for Apotex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apotex
Apotex has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Aveva and Searchlight Pharma.
Investment portfolio details for Apotex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
Specialty pharmaceuticals are acquired, developed, and commercialized by the company. | Locked | Locked | 2015 | Locked | |
Drugs for multiple therapeutic areas are manufactured by Aveva. | Locked | Locked | 2003 | Locked |
Complete acquisition details for Apotex
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Apotex
Detailed financials for Apotex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apotex Comparisons
Peer comparison for Apotex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Apotex
Detailed competitors of Apotex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apotex
Complete news archive for Apotex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apotex
Apotex was founded in 1974.
Apotex is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Allan Oberman is the current CEO of Apotex.
As of Apr 09, 2024, the latest employee count at Apotex is 1,236.
Annual revenue of Apotex is $76.64M as on Mar 31, 2023.
Apotex was founded in 1974 in Toronto, Canada, within the pharmaceutical sector. Generic formulations are produced by the company, with operations including research and development on both generic and innovative drugs. Products are distributed to every pharmacy in Canada and exported to various countries worldwide. Ferriprox has been approved for managing iron overload in patients with Thalassemia.
Yes, Apotex is publicly traded on TSX under the ticker symbol APTX.
Apotex has made 2 acquisitions, including Aveva, and Searchlight Pharma.
Apotex has 1 investor. Key investors include SK Capital.
The ticker symbol of Apotex is APTX on TSX.